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Most mammalian cells have in their plasma membrane
at least two types of lipid microdomains, non-invagi-
nated lipid rafts and caveolae. Glycosylphosphatidyli-
nositol (GPI)-anchored proteins constitute a class of
proteins that are enriched in rafts but not caveolae at
steady state. We have analyzed the effects of abolishing
GPI biosynthesis on rafts, caveolae, and cholesterol lev-
els. GPI-deficient cells were obtained by screening for
resistance to the pore-forming toxin aerolysin, which
uses this class of proteins as receptors. Despite the ab-
sence of GPI-anchored proteins, mutant cells still con-
tained lipid rafts, indicating that GPI-anchored proteins
are not crucial structural elements of these domains.
Interestingly, the caveolae-specific membrane proteins,
caveolin-1 and 2, were up-regulated in GPI-deficient
cells, in contrast to flotillin-1 and GM1, which were ex-
pressed at normal levels. Additionally, the number of
surface caveolae was increased. This effect was specific
since recovery of GPI biosynthesis by gene recomple-
mentation restored caveolin expression and the number
of surface caveolae to wild type levels. The inverse cor-
relation between the expression of GPI-anchored pro-
teins and caveolin-1 was confirmed by the observation
that overexpression of caveolin-1 in wild type cells led to
a decrease in the expression of GPI-anchored proteins.
In cells lacking caveolae, the absence of GPI-anchored
proteins caused an increase in cholesterol levels, sug-
gesting a possible role of GPI-anchored proteins in cho-
lesterol homeostasis, which in some cells, such as Chi-
nese hamster ovary cells, can be compensated by
caveolin up-regulation.
According to the current view, the plasma membrane of
mammalian cells is not a homogeneous sea of lipids but is
composed of different domains with different lipid and protein
compositions and different physical states. In particular, in-
creasing evidence supports the existence of cholesterol and
glycosphingolipid rich domains, which have been termed lipid
rafts (1, 2). Rafts are physiologically important since they have
been implicated in signaling (3, 4), cell adhesion (5), and cho-
lesterol homeostasis (4, 6, 7), as well as in pathological pro-
cesses such as proteolytic processing of the amyloid precursor
protein (8, 9) or infection by microorganisms (10).
Lipid rafts are small (50–350 nm in diameter depending on
the study, cell type, and analysis method) and highly dynamic
entities (11). Due to the high abundance of cholesterol and
lipids with long saturated acyl chains, the lipid bilayer within
these domains is in the tightly packed liquid ordered state Lo
(12). Some proteins preferentially partition into Lo phases,
leading to a specific protein composition (2). More than 100
proteins have been suggested to be associated with lipid rafts.
Even though this might be an overestimation, considering the
small size of elementary raft units, a given raft can only con-
tain a limited number of these proteins. It is not clear at
present whether each raft contains a random sample of raft
components or whether some rafts contain a specific set of
proteins or lipids, i.e. whether there are different types of rafts.
A clear subclass of rafts is, however, composed by caveolae
(13). These can easily be distinguished by their shape (they are
flask-like invaginations) and by the presence of membrane
proteins of the caveolin family (4, 7, 13). The proposed func-
tions of caveolae are similar to those attributed to rafts. They
are believed to be implicated in signal transduction, based on
the observation that caveolin-1 interacts with a number of
signaling molecules (14), and in cholesterol regulation (4, 7). In
the present paper, for the sake of clarity, the term raft will only
be used to identify all non-caveolar rafts, as opposed to caveolae
themselves. In contrast to rafts, caveolae are not ubiquitous
since they are not found in cells lacking caveolins such as
lymphocytes (15). However, heterologous expression of caveo-
lin-1 will induce de novo formation of caveolae (16–18).
A class of raft proteins that has attracted much attention
over the last decade is that of GPI1-anchored proteins (GPI-
APs). These lipid-anchored polypeptides are mainly present at
the plasma membrane where they are found in rafts, i.e. out-
side of caveolae, at steady state (19), even though they may
enter caveolar pits upon cross-linking with antibodies (20).
GPI-anchored proteins, however, also undergo endocytosis. In
CHO cells, they were shown to be internalized and then recy-
cled back to the plasma membrane via the recycling endosome
(21)2 in a cholesterol-dependent (21) and sphingolipid-depend-
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ent (22) process. In COS-7 cells, although GPI-anchored pro-
teins were found to cycle between the plasma membrane and
theGolgiapparatus,traffickingwasagainfoundtobecholesterol-
dependent (23), further highlighting the functional interac-
tions between GPI-APs and cholesterol.
We here investigated whether the absence of GPI-anchored
proteins would affect lipid rafts and/or caveolae. We have
used GPI-deficient lymphocytes and CHO cells. The GPI-
deficient CHO cells were obtained by screening for resistance
toward the bacterial pore-forming toxin aerolysin, which
binds specifically to GPI-APs (24 –26). Interestingly, we
found that GPI-deficient CHO cells express higher levels of
caveolin-1 than wild type cells, due to increased transcrip-
tion, and concomitantly have an increased number of caveo-
lae at their surface. Restoration of GPI biosynthesis by gene
recomplementation subsequently reduced caveolin-1 expres-
sion to wild type levels. These experiments indicate that cells
that lack GPI-anchored proteins somehow compensate for
this loss by overexpressing caveolins. Comparison of GPI-
deficient cells, which naturally express caveolins (CHO) or
lack caveolins (lymphocytes), suggests that caveolin overex-
pression might compensate for cholesterol defects.
EXPERIMENTAL PROCEDURES
Materials—Monoclonal anti-caveolin-1 and anti-caveolin-2 antibod-
ies were purchased from Transduction Laboratories (Lexington, KY),
polyclonal anti-caveolin-1 N20 antibodies from Santa Cruz, monoclonal
anti-transferrin receptor antibodies from Zymed Laboratories Inc.,
polyclonal anti-LAT from Upstate Biotechnology (Lake Placid, NY), and
monoclonal mouse anti-FLAG antibodies from Sigma and horseradish
peroxidase-conjugated secondary antibodies from Amersham Pharma-
cia Biotech. Anti-Rab 5, anti--COP, anti-p23, anti-1-2 adaptins,
anti-calnexin, and anti-flotillin antibodies were gifts from R. Jahn
(MPI, Tu¨bingen), the late T. Kreis, J. Gruenberg (University of Geneva,
Geneva), A. Dautry-Varsat (Pasteur Institute, Paris), A. Helenius
(ETH, Zu¨rich), and P. Bickel (Harvard, Cambridge, MA), respectively.
Fluorescent secondary antibodies were from Jackson Immunoresearch.
Peroxidase-coupled cholera toxin B-subunit was purchased from Sigma.
cDNAs of PIG-L and PIG-A were those previously generated (27, 28).
The caveolin-1 cDNA was a gift from P. Dupree (University of Cam-
bridge, Cambridge) (29).
Proaerolysin Purification, Iodination, and Activation—Proaerolysin
was purified as described previously (30). Concentrations were deter-
mined by measuring the optical density at 280 nm, considering that a 1
mg/ml sample has an optical density of 2.5 (31). Proaerolysin was
labeled with 125I using IODOGEN reagent (Pierce) according to the
manufacturer’s recommendations. The radiolabeled toxin was sepa-
rated from the free iodine by gel filtration on a PD10-G25 column
(Amersham Pharmacia Biotech) equilibrated with 150 mM NaCl, 20 mM
HEPES, pH 7.4. We consistently obtained a specific activity of about
2  106 cpm/g of proaerolysin. Radiolabeled proaerolysin ran as a
single band on a SDS gel.
Cell Culture and Isolation of Proaerolysin-resistant Mutants—
CHO-K1 cells were routinely maintained in 100-mm diameter Nunc
dishes containing 10 ml of F-12 medium supplemented with 10% fetal
calf serum and 2 mM L-glutamine under standard tissue culture condi-
tions in a 5% CO2 atmosphere at 100% humidity at 37 °C. CHO-K1 cells
were mutagenized with ethyl methanesulfonate (400 g/ml) at 37 °C for
24 h, as described (32). After growing in the complete culture medium
for 4 days, the mutagenized cells were harvested, re-seeded at 400
colonies/dish, and grown in the presence of 1 nM proaerolysin for an-
other 2 days. After incubation in toxin-free culture medium for 7 days,
surviving colonies were trypsinized with a filter paper and transferred
to 24-well plates. The cells were cultured in normal medium for several
days, re-seeded, and then subjected to two other cycles of proaerolysin
selection as above. A total of 314 separated colonies of surviving cells
were formed and purified by limited dilution. After confirming toxin
resistance, clones were frozen for further analysis.
Proaerolysin Binding—Confluent monolayers of CHO cells were
washed three times with ice-cold PBS containing 1 mM CaCl2 and 1 mM
MgCl2 (PBS
2). Cells were then incubated at 4 °C with 0.4 or 0.96 nM
125I-proaerolysin in incubation medium containing Glasgow minimal
essential medium buffered with 10 mM HEPES, pH 7.4, for 1 h. Cells
were washed three times for 5 min with PBS2 at 4 °C. Monolayers
were then further incubated at 37 °C in incubation medium for various
times. Cells were subsequently washed with ice-cold PBS2, scraped
from the dish, and collected by centrifugation at 300  g for 5 min. The
presence of cell-bound 125I-proaerolysin was analyzed either by count-
ing or by autoradiography of 10% SDS gels.
Proaerolysin Overlays—Proaerolysin overlays, to detect proaerolysin
receptors, were performed as described previously (25). Briefly, mem-
brane fractions were run on a 10% SDS gel (33). The gel was incubated
in 50 mM Tris-HCl, pH 7.4, and 20% glycerol for 10 min. Proteins were
then blotted onto a nitrocellulose membrane for 16 h at 100 mA in the
cold using a Bio-Rad wet transfer chamber with a transfer buffer
containing 10 mM NaHCO3 and 3 mM Na2CO3 (pH 9.8). The nitrocellu-
lose membrane was incubated in a binding buffer containing 50 mM
NaH2PO4, pH 7.5, and 0.3% Tween 20 for 20 min, followed by a 2-h
incubation in the presence of 2.8 nM proaerolysin (labeled or not with
125I) diluted in the same buffer. The membrane was then washed six
times for 5 min with toxin free binding buffer. Binding of proaerolysin
was revealed by autoradiography using BioMax films (Eastman Kodak
Co.) or using anti-aerolysin antibodies.
Plasmids, Transfections, and Generation of Stable Cell Lines—PIG-L
and PIG-A genes were expressed in a pMEori expression vector (pME-
EBO-FLAG) driven by Sr- promoter composed of human T-cell lym-
photrophic virus-1 enhancer and simian virus 40 early promoter (27).
Caveolin-1 gene was introduced in the pcDNA3 vector driven by the
human cytomegalovirus promoter. Plasmids were purified using col-
umns (Quiagen Inc., Chatsworth, CA) according to the manufacturer’s
instructions. Transfection experiments in CHO cells were performed by
the CaPO4-DNA precipitation procedure described by Graham and
FIG. 1. Proaerolysin-resistant CHO mutant cell lines can no
longer bind the toxin due to the loss of the cell surface GPI-
anchored receptors. A, histogram of 125I-proaerolysin binding. Mono-
layers of CHO wild type and mutant cells were incubated with 125I-
proaerolysin (1 nM) for 1 h at 4 °C, extensively washed, and incubated
for an additional 20 min at 37 °C. The amount of radioactivity associ-
ated with the cells was counted and expressed as a percentage of the
CHO wild type associated radioactivity (n  4). The numbers refer to
the name of mutant cell lines obtained after screening for aerolysin
resistance (see text). B, absence of GPI-130 in proaerolysin binding-
deficient CHO mutants revealed by proaerolysin overlay. 40 g of
postnuclear supernatant of each cell type were submitted to a proaero-
lysin overlay assay.
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van der Eb (34), using caveolin-1, PIG-L, or PIG-A expression con-
structs. CHO cells from a confluent 60-cm2 tissue culture dish were
diluted 1:15 and seeded on glass coverslips in a six-well tissue culture
plate in view of immunofluorescence experiments. Per well, 3 g of
plasmid DNA were used. The expressing cells were analyzed by immu-
nofluorescence after 48 h of incubation at 37 °C. To establish stable cell
lines expressing FLAG-PIGL or FLAG-PIGA, transfectants were se-
lected with culture medium containing 200 g/ml hygromicin. Stable
cell lines expressing caveolin-1 were selected for resistance toward 600
g/ml G418. After three cycles of trypsinization and antibiotic treat-
ment, colonies were isolated by limited dilution.
Purification of Detergent-resistant Membranes (DRMs)—Approxi-
mately 2  107 cells were resuspended in 0.5 ml of cold buffer (TNE)
containing 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, and 1%
Triton X-100 (Ultrapure, Pierce) with a tablet of Complete (Roche
Molecular Biochemicals), a mixture of protease inhibitors. Membranes
were solubilized by rotary shaking at 4 °C for 30 min. The DRMs were
purified on either a step sucrose gradient (25) or using an Optiprep
gradients (35). For purification on sucrose gradients, the cell lysate was
adjusted to 40.7% sucrose (in 10 mM Tris-HCl, pH 7.4), loaded at the
bottom of a SW 40 Beckman tube, overlaid with 8 ml of 35% sucrose,
topped up with 15% sucrose, and centrifuged for 18 h at 35,000 rpm at
4 °C. After centrifugation, 12 fractions of 1 ml were collected. For each
fraction the protein content was determined. The same protein amount
of each fraction was precipitated and analyzed by SDS-PAGE, followed
by toxin overlay and/or Western blot analysis. For purification on Op-
tiprep gradients, the cell lysate was adjusted to 40% Optiprep, loaded at
the bottom of a TLS.55 Beckman tube, overlaid with 600 l of 30%
Optiprep and 600 l of TNE, and centrifuged for 1.5 h at 55,000 rpm at
4 °C. Six fractions of 250 l were collected from top to bottom. DRMs
were found in fraction 3, which were subsequently precipitated with
chloroform methanol and analyzed as above.
Two-dimensional Gel Analysis—DRMs were prepared from wild type
and mutant CHO cells as described (36) and precipitated with 6%
trichloroacetic acid in the presence of 375 g of sodium deoxycholate as
a carrier. Two-dimensional gel electrophoresis was performed with
non-linear immobilized pH gradient strips, pH range 3–10 (Amersham
Pharmacia Biotech, Uppsala, Sweden) as described (36, 37).
Northern Blotting of Caveolin mRNA—Total RNA was purified from
CHO wild type or LA1 cell monolayers with Nucleospin RNA II kits
(Macherey-Nagel). Confluent cells in one 10-cm dish yielded 10 g of
total RNA. For Northern blot analysis, 1.25 g of RNA were separated
on 1% agarose/formaldehyde denaturing gel and transferred on to a
nylon membrane. The membrane was stained with methylene blue
(presence of 28 and 18 S ribosomal RNA bands indicating intact RNA)
and was hybridized to full-length random-primed 32P-labeled (random-
primed DNA labeling kit, Roche Molecular Biochemicals) caveolin
cDNA (EcoRI-XhoI insert of 890 base pairs). The caveolin blot was
FIG. 2. Recovery of proaerolysin sensitivity upon transfection
of CHO-LA1 cells with the PIG-L gene. A, effect of proaerolysin on
the morphology of CHO-LA1 in the absence (left) or presence (right) of
the PIG-L gene. Cells were incubated with 0.4 nM proaerolysin at 37 °C
for 1 h. Bar  10 m. B, recovery of GPI biosynthesis upon transfection
of CHO-LA1 cells with the PIG-L gene. GPI-anchored proteins were
detected by aerolysin overlay on PNS (40 g) of wild type cells, CHO-
LA1, and CHO-LA1 recomplemented with the PIG-L gene. Calnexin
was used as an equal loading marker.
FIG. 3. Characterization of CHO-LA1 cells. A, growth of GPI-
deficient CHO-LA1 cells was found to be indistinguishable from that of
wild type and PIG-L recomplemented cells. Values represent the mean
of three experiments. B, PNS were prepared from wild type cells,
CHO-LA1, and CHO-LA1 recomplemented with the PIG-L gene. West-
ern blot analysis (40 g of protein loaded/lane) shows that cellular
levels of 1-2 adaptins, the small GTPase Rab5, the transferrin recep-
tor (Tf-R), -COP, and p23, one of the p24 family members, were similar
in wild type, mutant, and recomplemented cells.
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prehybridized for 24 h at 65 °C and then hybridized overnight at 65 °C
to the probe at 1 10.6 cpm/ml hybridization buffer. Washed blots were
visualized on Kodak X-Omat film, exposed to a phosphorimager plate,
and analyzed using Quantity One software (Bio-Rad) under conditions
where the signals were linear with respect to the amount of sample
applied.
Immunofluorescence—Fixation and permeabilization of CHO cells
were performed by incubation 4 min at 20 °C in methanol. After three
washes in PBS plus 0.05% bovine serum albumin, fixed cells were
reacted for 30 min at room temperature with polyclonal anti-caveolin 1
antibodies (1:100). Cells were then washed three times with PBS, 0.5%
bovine serum albumin and incubated for 30 min at room temperature
with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (1:50).
Cells were analyzed with a Zeiss Axiophot fluorescence microscope.
Cholesterol Quantification by Thin Layer Chromatography—Lipids
were chloroform/methanol-extracted from cell extract (equivalent of 40
g of protein). Lipids were separated on Kiesel gel 60 (Merck, Germany)
with a solvent system of heptane:ethyl ether:acetic acid (18:6:2). Cho-
lesterol was visualized after incubating the sheet in a solution of 3%
copper acetate with 8% H3PO4 and drying 5 min at 160 °C. TLC plates
were then analyzed by densitometry and cholesterol amount quantified
using Scan-Analysis software.
Other Methods—To quantify cell growth, wild type and mutant
CHO cells were seeded in complete medium at the density of 4.105
cells/ml at day 0 and counted every 24 h. Cell surface caveolae were
quantitated by electron microscopy exactly as described previously
(38). SDS-PAGE was performed as described by Laemmli (33). West-
ern blot analysis was carried out using peroxidase-conjugated sheep
anti-mouse or anti-rabbit IgG as a secondary antibody, which was
detected by chemiluminescence using Super Signal reagents (Pierce).
Protein concentrations of cellular fractions were determined with
bicinchoninic acid (BCA, Pierce).
RESULTS AND DISCUSSION
Generation of CHO Mutant Cell Lines Deficient in GPI Bio-
synthesis—In order to generate cell deficient in GPI biosynthe-
sis, we have made use of the bacterial pore-forming toxin aero-
lysin (26). This toxin specifically binds to GPI-anchored
proteins on mammalian cells, and the binding capacity is re-
tained after SDS-PAGE of cellular extracts and blotting onto a
nitrocellulose membrane (toxin overlay assay) (24, 25). The
main determinant for aerolysin binding is not the protein moi-
ety but the glycan core common to all GPI-anchored proteins
(39). Therefore, aerolysin does not generally discriminate be-
tween different GPI-anchored proteins, although some excep-
tions exist (40). Thus, all cells expressing GPI-anchored pro-
teins are likely to be sensitive to aerolysin and will ultimately
dye when exposed to the toxin (25). Conversely, cells lacking
GPI-anchored proteins should be insensitive to aerolysin, as
suggested by several examples (40, 41) and should therefore
multiply even in the presence of the toxin. Aerolysin therefore
potentially constitutes a very powerful tool to generate GPI-
deficient cells. We found that this is indeed the case by screen-
ing for aerolysin-resistant CHO cells. We have recently identi-
fied and characterized the GPI-anchored protein composition of
CHO cells by two-dimensional gel analysis2 and shown that a
protein with apparent molecular mass of 130 kDa is by far the
most abundant GPI-anchored protein in this cell type. This
protein, called here GPI-130, can readily be detected by per-
forming an aerolysin overlay assay on a postnuclear superna-
tant after one-dimensional SDS-PAGE (can be seen in Fig. 1B).
Cells were submitted to chemical mutagenesis with EMS
and then selected for the ability to grow in the presence of 1 nM
proaerolysin, the aerolysin precursor (for review see Ref. 26).
Among 314 mutants, most were unable to bind aerolysin (Fig.
1A) and 9 were selected for further analysis. In agreement with
the lack of proaerolysin binding, we could not detect GPI-130
by toxin overlay in any of the mutants (identified by numbers in
Fig. 1B). The absence of GPI-130 suggested that the cells might
FIG. 4. Isolation of detergent-resistant membranes from wild
type and CHO-LA1 cells. DRMs were purified from wild type and
CHO-LA1 cells using sucrose flotation gradients. A, fractions were
collected from the top to the bottom of the gradient and equal amounts
of proteins (20 g) from each fraction were separated by SDS-PAGE and
blotted onto nitrocellulose. The distribution of GPI-anchored proteins
was analyzed by aerolysin overlay and that of caveolin-1, flotillin-1, and
the transferrin receptor (Tf-R) by Western blotting. B, the two-dimen-
sional protein map of DRMs from wild type and LA1 CHO cells were
obtained by two-dimensional gel electrophoresis followed by high sen-
sitivity silver staining. The repeated two-dimensional gel analysis of
DRMs from the two cell types as well as the comparison of the gels using
the MELANIE two-dimensional gel analysis software indicated that the
protein patterns were essentially identical. GPI-anchored proteins are
not detectable on the gel of CHO wild type cells, because the DRMs were
not treated with PI-phospholipase C (36) prior to two-dimensional SDS-
PAGE and, moreover, CHO GPI-anchored proteins are not abundant
enough to be seen on such a gel. IEF, isoelectric focusing; IPG, immo-
bilized pH gradient.
FIG. 5. Isolation of DRMs from lymphocytes expressing or
not expressing GPI-anchored proteins. DRMs were purified from
wild type and class A BW5147 cells using sucrose flotation gradients.
Fractions were collected from the top to the bottom of the gradient,
and equal amounts of proteins (20 g) from each fraction were ana-
lyzed by SDS-PAGE and Western blotting using anti-flotillin and
LAT antibodies.
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indeed be deficient in the biosynthesis of GPI-anchored pro-
teins in general. This was confirmed by the observation that
none of the mutants were able to heterologously express the
GPI-anchored protein human alkaline phosphatase (data not
shown).
CHO mutants deficient in GPI biosynthesis have previously
been generated by EMS mutagenesis (for reviews see Refs. 42
and 43). Most of the obtained mutants were deficient in the
enzyme responsible for the N-deacetylation of N-acetylglu-
cosamine phosphatidylinositol, which is encoded by the PIG-L
gene (27, 44). We therefore tested whether our mutants were
also PIG-L-deficient, by transfecting cells with a PIG-L con-
struct. Expression of alkaline phosphatase and sensitivity to-
ward proaerolysin were assayed. Among the nine selected mu-
tants, only the CHO-LA1 mutant cell line (labeled 1 in Fig. 1B)
was sensitive toward proaerolysin after PIG-L transfection, as
witnessed by a recovery of ER vacuolation, a characteristic
effect of aerolysin on fibroblast-like cells (25, 45) (Fig. 2A). A
second frequent target gene of EMS mutagenesis is the DMP2
gene, encoding an ER protein implicated in the synthesis of
dolichol-phosphate mannose, a mannose donor for GPI as well
as for N-glycans and C-mannosylation (46). By gene recomple-
mentation, we found that mutant CHO-LA49 (labeled 49 in
Fig. 1B) was affected in the DMP2 gene. It remains to be
determined what step of GPI biosynthesis is affected in the
other mutant cells.
Characterization of the CHO-LA1 GPI-deficient Cell Line—
The CHO-LA1 GPI-deficient cell line was chosen for further
analysis, and a stable CHO-LA1 cell line expressing the PIG-L
gene was generated. In agreement with their sensitivity to-
ward aerolysin (Fig. 2A), CHO-LA1 cells recomplemented with
the PIG-L gene were able to express GPI-130 (Fig. 2B).
We first checked that the absence of GPI-anchored proteins did
not drastically affect cellular physiology. As shown in Fig. 3A, the
growth curve of CHO-LA1 was similar to that of wild type and
PIG-L recomplemented cells. We next verified that a variety of
proteins involved in key cellular functions were expressed to
normal levels. The 1-2 adaptins, implicated in clathrin-
mediated vesicular transport (47), and the small GTPase Rab5,
involved in early steps of endocytosis (48), were expressed to
similar levels in wild type and GPI-deficient LA1 cells (Fig. 3B).
Also levels of transferrin receptor and of -COP, one of the
components of the COPI coat involved biosynthetic and endocytic
transport (49, 50), were similar in wild type and mutant cells
(Fig. 3B). Finally, we analyzed the levels of p23, a type I mem-
brane protein that has been implicated in organizing the early
secretory pathway (51) as well as in transport of GPI-anchored
proteins in yeast (52, 53). Levels of p23 were also similar in wild
type and mutant cells (Fig. 3B).
The above observations suggest that the absence of GPI-
anchored protein does not grossly alter the physiology of CHO
cells in culture. This contrasts with the importance of GPI-
anchored proteins in mouse embryonic development (54).
Existence of Rafts in GPI-deficient Cells—We next investi-
gated whether the absence of GPI-anchored proteins affected
raft integrity. Since rafts have the biochemical property of
being resistant to certain non-ionic detergents at 4 °C, we have
analyzed whether DRMs could be purified by flotation gradi-
ents from CHO-LA1 as from wild type CHO cells. As shown in
Fig. 4A, DRMs could readily be obtained from mutant cells and
were enriched in caveolin-1 as well as flotillin-1, a protein
FIG. 6. Effects of GPI deficiency on the levels of raft/caveolae
markers. A, PNS were prepared from wild type cells, CHO-LA1, and
CHO-LA1 recomplemented with the PIG-L gene. The amounts of caveo-
lin-1, caveolin-2 and flotillin were assayed by Western blot analysis (40
g of total protein/lane). Calnexin was used as an equal loading marker.
The amounts of GM1 were analyzed by dot blot using peroxidase-
coupled cholera toxin B-subunit. B, PNSs were prepared from wild type
and various GPI-deficient cell lines (the numbers refer to the mutant
cell lines, obtained after screening for aerolysin resistance, which no
longer express GPI-130 or alkaline phosphatase (see text and Fig. 1)).
The amounts of caveolin-1was assayed by Western blot analysis (30 g
of total protein/lane). Calnexin was used as an equal loading marker.
FIG. 7. Up-regulation of caveolin-1 in GPI-deficient cells. A, the
distribution of caveolin-1 was analyzed by immunofluorescence on wild
type and CHO-LA1 cells. Cells were fixed and permeabilized with
methanol and incubated for 30 min at room temperature with poly-
clonal anti-caveolin -1 antibodies, followed by 30 min with fluorescein
isothiocyanate anti-rabbit IgGs. Bars  10 m. B, detection of caveolin
mRNA by Northern blot analysis using the full-length caveolin-1 DNA
as probe on 1.25 g of total RNA of wild type or LA1 CHO cells.
Quantification using a phosphorimager revealed a 2.3-fold increase in
caveolin-1 mRNA (n  2).
TABLE I
The number of cell surface caveolae is increased in
GPI-deficient CHO cells
Wild type LA1 LA1  PIG-L
No. of caveolae 65 108 61
No. of unit cells counted 60 60 60
No. of caveolae/unit cell 1.1 1.8 1.0
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reported to be associated with caveolae and other subdomains
of the plasma membrane (55–57). Note that after purification of
DRMs, two additional GPI-anchored proteins could be detected
by toxin overlay in wild type cells, GPI-40, and GPI-60. The
protein composition of DRMs from wild type and GPI-deficient
cells was very similar as witnessed by two-dimensional gel
analysis (Fig. 4B).
The only detectable different between DRMs from wild type
and GPI-deficient cells as analyzed in Fig. 4A was that the
latter contained more caveolin-1. This raised the possibility
that CHO-LA1 cells might have fewer or no rafts and compen-
sate for this loss by forming a greater number of caveolae. Since
both rafts and caveolae are found in DRMs, the analysis of
DRMs of CHO cells does not allow to address this issue.
We therefore analyzed lymphocytes since they lack caveolae
(15). DRMs were prepared from control lymphocytes (BW5147)
and mutants, which are deficient in the first step of GPI bio-
synthesis, i.e. the transfer of N-acetylglucosamine to phos-
phatidylinositol (58) (BW5147/A; Ref. 59). As raft markers, we
have used flotillin-1 and the transmembrane protein linker for
activation of T cells (LAT) (60). As shown in Fig. 5, DRMs,
enriched in flotillin-1 and LAT, could be obtained from both
wild type and GPI-deficient lymphocytes, indicating that GPI-
anchored proteins are not necessary for the structural integrity
of rafts. Since BW5147/A cells are mutated in the first step in
GPI biosynthesis (42, 58), these cells also lack non-protein-
linked or so-called free GPIs. These free glycolipids are abun-
dant in many mammalian cells (105 to 107 molecules/cell; Ref.
61), and are found at the plasma membrane as well as in
intracellular organelles (62). The physiological role of free GPIs
is not known. They are, however, likely to concentrate in rafts
since they share the same lipid moiety as GPI-anchored pro-
teins. The present observations demonstrate that not only GPI-
anchored proteins but also free GPIs are not required for raft
integrity.
Increased Expression of Caveolin-1 in GPI-deficient Cell
Lines—The observation that caveolin-1 was more enriched in
DRMs of CHO-LA1 cells than in those of wild type cells (Fig.
4A) could be due to a stronger association of caveolin-1 with
DRMs in the mutant cells or to higher expression levels of this
protein. We therefore compared the amounts of caveolin-1 in
postnuclear supernatants of wild type and CHO-LA1 cells.
Care was taken to perform experiments on wild type and mu-
tant cells that were at similar confluence since cell confluence
can affect the level of caveolin-1 expression (63). As shown in
Fig. 6A, the total amount of caveolin-1 was higher in CHO-LA1
cells but was restored to normal levels upon expression of the
PIG-L gene, but not of the PIG-A gene (data not shown). The
increase in caveolin-1 in LA1 cells was accompanied by an
up-regulation of caveolin-2 (Fig. 6A). The levels of other mark-
ers of DRMs such as flotillin-1 and GM1 were, however, not
affected (Fig. 6A), suggesting that the absence of GPI-anchored
protein specifically affects caveolin levels.
According to this hypothesis, all mutant cell lines deficient in
GPI biosynthesis should express higher levels of caveolin-1
than wild type cells, independently of the gene in the GPI
biosynthesis that is mutated. As shown in Fig. 6B, this is
indeed the case: all our previously mentioned GPI-deficient cell
lines (which no longer express GPI-130, as shown in Fig. 1, or
exogenous alkaline phosphatase) showed increased levels of
caveolin-1. One possibility could have been that the increase of
caveolin-1 is not due to the absence of GPI-anchored proteins
but rather to the accumulation of GPI intermediates. This
FIG. 8. Down-regulation of GPI-anchored proteins upon over-
expression of caveolin-1. A, CHO cell lines overexpressing caveolin-1
(called CHO C1 and C3) to various extents were generated. The
amounts of caveolin-1 in the various cell types were analyzed by West-
ern blotting (40 g of protein loaded/lane). B, the levels of GPI-anchored
proteins in caveolin-1-overexpressing cells was measured by aerolysin
overlay on DRMs prepared using Optiprep gradients. C, histogram of
125I-proaerolysin binding. Monolayers CHO wild type and caveolin-1-
overexpressing cells were incubated with 125I-proaerolysin (0.4 nM) for
1 h at 4 °C and extensively washed. The amount of radioactivity asso-
ciated with the cells was counted, normalized to the amount of protein,
and expressed as a percentage of the CHO wild type-associated radio-
activity (n  4).
FIG. 9. Cholesterol levels in GPI-deficient cells. The total cho-
lesterol content of wild and GPI-deficient CHO cells as well as wild type
and class A BW5147 lymphocytes was measured by TLC analysis on cell
extracts (equivalent of 40 g of protein). TLC plates were then analyzed
by densitometry (n  3).
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seems unlikely for the following reasons. First, CHO-LA1 and
CHO-LA49 are mutated in two proteins involved in the early
steps of GPI biosynthesis and therefore accumulate GlcNAc-PI
but not mannosylated intermediates. Second, although CHO-
LA49 cells are likely to accumulate less GlcNAc-PI then CHO-
LA1 (see reason below), they express similarly high levels of
caveolin-1 as CHO-LA1 cells. As mentioned above, CHO-LA49
cells were affected in DPM2, a protein that has been shown to
regulate the GPI-N-acetyl glucosaminyltransferase (64). In the
absence of DPM2, the enzyme activity of GPI-N-acetyl glu-
cosaminyltransferase was found to be reduced by 3-fold leading
to a decreased production of the GPI intermediate GlcNAc-PI.
Increase in the Number of Caveolae in GPI-deficient CHO-
LA1 Cells—Up-regulation of caveolin-1 has been shown previ-
ously to be accompanied by an increase in the number of
caveolae (38, 65, 66). Immunofluorescence analysis of wild type
and CHO-LA1 suggested that indeed the number of caveolae
was higher in the GPI-deficient cells (Fig. 7A) since the punc-
tate staining pattern appeared more intense and dense for
CHO-LA1 cells. This was confirmed when analyzing the cells
by electron microscopy. Non-coated 50–100-nm flask-shaped
invaginations at the plasma membrane, typical of caveolae,
were counted for each cell type. CHO-LA1 cells had almost
twice as many caveolae as wild type (Table I). Importantly, the
number of caveolae returned to wild type levels when LA1 cells
were recomplemented with the PIG-L gene.
This higher expression of caveolin-1 in CHO-LA1 is most
likely due to an increase in transcription since the level of
caveolin-1 mRNA was increased by 2.5-fold when compared
with wild type cells, as determined by Northern blot analysis
using a caveolin-1 cDNA probe (Fig. 7B). We cannot, however,
exclude that mRNA stability was increased.
Inverse Correlation between the Levels of Caveolin-1 and of
GPI-anchored Proteins—The above experiments show that the
absence of GPI-anchored proteins leads to an up-regulation of
caveolins and an increase in the number of caveolae. To confirm
this apparent inverse correlation, we tested whether overex-
pression of caveolin-1 would lead to a reduction of the amount
of GPI-anchored proteins. Two cell lines, CHO C1 and C3, were
generated that overexpress caveolin-1 to different extents,
which are, however, lower than CHO-LA1 GPI minus cells (Fig.
8). As shown in Fig. 8, the increase in caveolin-1 levels was
accompanied by a decrease in the amounts of GPI-anchored
proteins (GPI-130, GPI-60, and GPI-40) as well as an expected
decrease in aerolysin binding (Fig. 8B).
The inverse correlation we have observed here between
caveolin-1 and GPI-anchored protein expression is consistent
with the previous observations that a reduction in caveolin-1 in
ovarian carcinoma leads to an increase in the levels of GPI-
anchored folate receptor (67) and that the overexpression of
placental alkaline phosphatase in baby hamster kidney cells
leads to a decrease in caveolin-1 levels (data not shown).
Effect of GPI Deficiency on Total Cholesterol Content—Fi-
nally, since GPI-anchored proteins are enriched in cholesterol-
rich membranes and since cholesterol appears to regulate
transport of GPI-APs (21, 23), we wondered whether the ab-
sence of GPI-anchored proteins would affect total cholesterol
contents. As shown in Fig. 9, all our CHO GPI-deficient cell
lines (described in Figs. 1 and 6) had total cholesterol contents
similar to those for wild type cells. Since caveolin-1 has been
shown to play a role in cholesterol homeostasis (6, 7), the
maintenance of wild type cholesterol levels in GPI-deficient
CHO cells could be due to the increased amount of caveolins. To
test this possibility, we measured total cholesterol levels in
wild type and GPI-deficient BW5147 lymphocytes. As shown in
Fig. 9, class A lymphocytes had a 2.1-fold higher cholesterol
level than wild type cells. Taken together, the above observa-
tions support the hypothesis that caveolins are up-regulated in
GPI-deficient CHO cells in response to cholesterol changes.
Conclusions—We here show that GPI-anchored proteins as
well as free GPIs are not required for the structural integrity of
lipids rafts. In agreement with our observations, it was recently
shown (68) that erythrocytes from patients with paroxysmal
nocturnal hemoglobinuria, which lack glycosylphosphatidyli-
nositol-anchored proteins (mutation in PIG A gene), still con-
tained rafts.
Interestingly, we found that in the absence of GPI-anchored
proteins, lymphocytes had elevated levels of cholesterol. Simi-
lar observations were made on paroxysmal nocturnal hemoglo-
binuria erythrocytes, which were found to have 2.37 times
more cholesterol than control erythrocytes (68). In contrast, we
found that CHO cells stringently maintain their cholesterol
levels in the absence of GPI-anchored proteins. One possible
explanation for the differences observed between lymphocytes
and erythrocytes, on one hand, and CHO cells, on the other, is
that the latter cells contain caveolins, which have been impli-
cated in cholesterol homeostasis. Strikingly, GPI-deficient
CHO cells express higher levels of caveolins than wild type
cells and have more caveolae at their plasma membrane. It is
therefore tempting to speculate that caveolins are up-regulated
in GPI-deficient cells in response to cholesterol changes. Fur-
ther investigation will be required to confirm the hypothesis
that GPI deficiency affects cholesterol regulation, in a manner
that can be compensated for by caveolins.
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